Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis

Raquel López-Vilella1,2, Borja Guerrero Cervera2, Víctor Donoso Trenado1,2

  • 1Heart Failure and Transplant Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Insights

Heart failure decompensation presents in four distinct clinical types, each with unique characteristics and varying survival rates. Understanding these profiles is crucial for managing heart failure patients effectively.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Research

Background:

  • Heart failure (HF) decompensation episodes are not uniform.
  • Understanding clinical heterogeneity is vital for patient management.

Purpose of the Study:

  • To characterize distinct clinical groups of heart failure decompensation.
  • To perform a survival analysis based on these identified groups.

Main Methods:

  • Retrospective analysis of 1,668 patients admitted for HF between 2018-2023.
  • Exclusion of patients who died during admission.
  • Classification into four HF types: low cardiac output, pulmonary congestion, mixed congestion, and systemic congestion.

Main Results:

  • Low output HF associated with reduced ejection fraction and biventricular dilation.
  • Systemic congestion linked to tricuspid regurgitation, right ventricular dysfunction, and impaired renal function.
  • 5-year survival was 49%, with pulmonary congestion having better survival and systemic congestion worse survival.

Conclusions:

  • Acute heart failure decompensation exhibits four distinct phenotypic profiles.
  • These profiles differ clinically and have varying prognoses.
  • Recognizing these phenotypes is essential for predicting short, medium, and long-term outcomes.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
122